Page 50 - Read Online

P. 50

using RT-PCR. Med Mol Morphol 2009;42:102-9. Estimates of worldwide burden of cancer in 2008:
22. Zhang T, Zhao D, Wang Q, Yu X, Cui Y, Guo L, Lu SH. GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
MicroRNA-1322 regulates ECRG2 allele speciﬁ cally and acts 37. Coburn NG. Lymph nodes and gastric cancer. J Surg Oncol
as a potential biomarker in patients with esophageal squamous 2009;99:199-206.
cell carcinoma. Mol Carcinog 2013;52:581-90. 38. Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ.
23. Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, MicroRNA dysregulation in gastric cancer: A new player
Wang WS, Jiang TF, Wu BL, Li EM, Xu LY. MiR-142-3p as enters the game. Oncogene 2010;29:5761-71.
a potential prognostic biomarker for esophageal squamous cell 39. Song S, Ajani JA. The role of microRNAs in cancers of the
carcinoma. J Surg Oncol 2012;105:175-82. upper gastrointestinal tract. Nat Rev Gastroenterol Hepatol
24. Leidner RS, Ravi L, Leahy P, Chen Y, Bednarchik B, 2013;10:109-18.
Streppel M, Canto M, Wang JS, Maitra A, Willis J, 40. Matuszcak C, Haier J, Hummel R, Lindner K. MicroRNAs:
Markowitz SD, Barnholtz-Sloan J, Adams MD, Chak A, Promising chemoresistance biomarkers in gastric cancer with
Guda K. The microRNAs, MiR-31 and MiR-375, as candidate diagnostic and therapeutic potential. World J Gastroenterol
markers in Barrett’s esophageal carcinogenesis. Genes 2014;20:13658-66.
Chromosomes Cancer 2012;51:473-9. 41. Song MY, Pan KF, Su HJ, Zhang L, Ma JL, Li JY, Yuasa Y,
25. Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Kang D, Kim YS, You WC. Identiﬁ cation of serum
Swisher SG, Wu TT, Ajani JA, Xu XC. Prognostic signiﬁ cance microRNAs as novel non-invasive biomarkers for early
of differentially expressed miRNAs in esophageal cancer. Int J detection of gastric cancer. PLoS One 2012;7:e33608.
Cancer 2011;128:132-43. 42. Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M,
26. Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Takeshita H, Morimura R, Nagata H, Arita T, Kawaguchi T,
Morimura R, Nagata H, Kosuga T, Iitaka D, Konishi H, Hirashima S, Fujiwara H, Okamoto K, Otsuji E. Detection
Shiozaki A, Fujiwara H, Okamoto K, Otsuji E. Circulating of gastric cancer-associated microRNAs on microRNA
microRNAs in plasma of patients with oesophageal squamous microarray comparing pre- and post-operative plasma. Br J
cell carcinoma. Br J Cancer 2011;105:104-11. Cancer 2012;106:740-7.
27. Zhang C, Wang C, Chen X, Yang C, Li K, Wang J, Dai J, 43. Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, Ma Y,
Hu Z, Zhou X, Chen L, Zhang Y, Li Y, Qiu H, Xing J, Xiao H. Genome-wide microRNA proﬁ les identify miR-378
Liang Z, Ren B, Yang C, Zen K, Zhang CY. Expression as a serum biomarker for early detection of gastric cancer.
proﬁ le of microRNAs in serum: a ﬁ ngerprint for esophageal Cancer Lett 2012;316:196-203.
squamous cell carcinoma. Clin Chem 2010;56:1871-9. 44. Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, Huang D,
28. Zhang T, Wang Q, Zhao D, Cui Y, Cao B, Guo L, Lu SH. The Chen X, Zhang H, Zhuang R, Deng T, Liu H, Yin J, Wang S,
oncogenetic role of microRNA-31 as a potential biomarker Zen K, Ba Y, Zhang CY. A ﬁ ve-microRNA signature identiﬁ ed
in oesophageal squamous cell carcinoma. Clin Sci (Lond) from genome-wide serum microRNA expression proﬁ ling
2011;121:437-47. serves as a ﬁ ngerprint for gastric cancer diagnosis. Eur J
29. Hummel R, Wang T, Watson DI, Michael MZ, Van der Cancer 2011;47:784-91.
Hoek M, Haier J, Hussey DJ. Chemotherapy-induced 45. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H,
modiﬁ cation of microRNA expression in esophageal cancer. Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H,
Oncol Rep 2011;26:1011-7. Okamoto K, Otsuji E. Circulating microRNAs in plasma of
30. Imanaka Y, Tsuchiya S, Sato F, Shimada Y, Shimizu K, patients with gastric cancers. Br J Cancer 2010;102:1174-9.
Tsujimoto G. MicroRNA-141 confers resistance to 46. Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z,
cisplatin-induced apoptosis by targeting YAP1 in human Cheng J, Xiao BX. Detection of circulating tumor cells in
esophageal squamous cell carcinoma. J Hum Genet peripheral blood from patients with gastric cancer using
2011;56:270-6. microRNA as a marker. J Mol Med (Berl) 2010;88:709-17.
31. Zhang H, Li M, Han Y, Hong L, Gong T, Sun L, Zheng X. 47. Li X, Zhang Y, Zhang Y, Ding J, Wu K, Fan D. Survival
Down-regulation of miR-27a might reverse multidrug prediction of gastric cancer by a seven-microRNA signature.
resistance of esophageal squamous cell carcinoma. Dig Dis Sci Gut 2010;59:579-85.
2010;55:2545-51. 48. Katada T, Ishiguro H, Kuwabara Y, Kimura M, Mitui A, Mori Y,
32. Hong L, Han Y, Zhang H, Li M, Gong T, Sun L, Wu K, Ogawa R, Harata K, Fujii Y. microRNA expression proﬁ le in
Zhao Q, Fan D. The prognostic and chemotherapeutic value undifferentiated gastric cancer. Int J Oncol 2009;34:537-42.
of miR-296 in esophageal squamous cell carcinoma. Ann Surg 49. Chen L, Jiang M, Yuan W, Tang H. Prognostic value of
2010;251:1056-63. miR-93 overexpression in resectable gastric adenocarcinomas.
33. Hamano R, Miyata H, Yamasaki M, Kurokawa Y, Hara J, Acta Gastroenterol Belg 2012;75:22-7.
Moon JH, Nakajima K, Takiguchi S, Fujiwara Y, Mori M, 50. Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X,
Doki Y. Overexpression of miR-200c induces chemoresistance Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ, Jimenez P,
in esophageal cancers mediated through activation of the Akt Rodriguez J, Garcia-Foncillas J. microRNA-451 regulates
signaling pathway. Clin Cancer Res 2011;17:3029-38. macrophage migration inhibitory factor production and
34. Hummel R, Watson DI, Smith C, Kist J, Michael MZ, Haier J, proliferation of gastrointestinal cancer cells. Clin Cancer Res
Hussey DJ. Mir-148a improves response to chemotherapy 2009;15:2281-90.
in sensitive and resistant oesophageal adenocarcinoma 51. Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B,
and squamous cell carcinoma cells. J Gastrointest Surg Gang Y, Zhang Y, Li Q, Qiao T, Zhao Q, Nie Y, Fan D.
2011;15:429-38. MiR-218 inhibits invasion and metastasis of gastric cancer by
35. Wu Y, Xiao Y, Ding X, Zhuo Y, Ren P, Zhou C, Zhou J. targeting the Robo1 receptor. PLoS Genet 2010;6:e1000879.
A miR-200b/200c/429-binding site polymorphism in the 3’ 52. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C,
untranslated region of the AP-2alpha gene is associated with Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K,
cisplatin resistance. PLoS One 2011;6:e29043. Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA,
36. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Croce CM. Relation between microRNA expression and

Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦ 151

45 46 47 48 49 50 51 52 53 54 55